Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor

Journal of Clinical Oncology

Volumn 19, Issue 3, 2001, Pages 689-696

  Eggert, A ^a   Grotzer, M A ^a   Ikegaki, N ^a   Zhao, H ^a   Cnaan, A ^a   Brodeur, G M ^a   Evans, A E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; LIGAND; MESSENGER RNA; NEUROTROPHIN; TYROSINE KINASE RECEPTOR;

ADOLESCENT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN TISSUE; INFANT; NEPHROBLASTOMA; NERVE CELL; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035253655     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.3.689     Document Type: Article

References (26)

1. Histopathology and prognosis of Wilms tumor: Results from the first national Wilms' tumor study
2. Etiology of Wilms' tumor
3. Surgical tactics in the treatment of malignant renal tumors in children
4. Pediatric genitourinary tumors
5. Anaplastic Wilms' tumor: Clinical and pathologic studies
6. Expression of insulin-like growth factor-II transcripts in Wilms' tumour
7. Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms' tumors: Expression at the mRNA and protein level
8. Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells
9. Association between high levels of expression of the Trk gene and favorable outcome in human neuroblastoma
10. Expression and function of Trk-B and BDNF in human neuroblastomas
11. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors
12. Signal transduction by the neurotrophin receptors
13. TrkC, a receptor for neurotrophin-3, is widely expressed in the developing nervous system and in non-neuronal tissues
14. The trkB tyrosine kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain
15. Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors
16. Functional receptors for nerve growth factor on Ewing's sarcoma and Wilm's tumor cells
17. Differential expression of neurotrophin receptors during renal development
18. Comparison between single-dose and divided-dose administration of dactinomycin and doxombicin for patients with Wilms' tumor: A report from the National Wilms Tumor Study Group
19. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: A report from the National Wilms Tumor Study Group
20. A relative quantitative RT-PCR protocol for TrkB expression in neuroblastoma using GAPD as an internal control
21. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome
22. Histological analysis of aggressiveness and responsiveness in Wilms' tumor
23. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells
24. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells
25. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity
26. Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor